Children's Health Defense A Michigan judge ruled that a lawsuit filed by the family of a man who died after receiving remdesivir contaminated with glass particles can proceed, despite claims by the drug’s manufacturer, Gilead Sciences, that it is shielded from liability under the Public Readiness and Emergency Preparedness, or PREP, Act.
By
A Michigan judge has ruled that a lawsuit against Gilead Sciences, the manufacturer of remdesivir, can move forward and be tried in the courts, despite claims by Gilead that it is protected under the Public Readiness and Emergency Preparedness (PREP) Act.
Remdesivir, an anti-viral drug sold under the brand name Veklury, was approved in May 2020 by the U.S. Food and Drug Administration (FDA) to treat COVID-19.
In her July 20 ruling, Judge Carol Kuhnke of the Circuit Court for the County of Washtenaw dismissed a motion for summary disposition filed by the defendants, Gilead Sciences and St. Joseph Mercy Chelsea Hospital.
Read Full Article Here…(childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
